Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

Immunological castration has the potential to make swine production more sustainable

Weighing the sustainability benefits of immunological castration in Europe

Immunological castration has the potential to improve the sustainability of European swine production, with proven benefits in terms of pork quality, economic performance, animal welfare and environmental impact. This alternative is not yet widely used in Europe, where physical castration is still common practice in most countries. But with a clearer framework for measuring the sustainability of this technique, scientists believe that immunological castration could gain greater market acceptance.

In a report in Sustainability,1 a team of scientists in Europe said that male piglets in Europe have been physically castrated for centuries to avoid some of the negatives of rearing boars. Barrows (castrated male pigs) have a lower risk of boar taint, an unpleasant odor that can occur when cooking meat from sexually mature male pigs. Reduced aggression in barrows is also linked to better welfare and carcass quality, they noted.

However, they added, physical castration has come under criticism in recent years in Europe “because it is painful and hurts the animals’ integrity.” Meanwhile, there is growing recognition of the economic and environmental benefits of keeping boars intact, such as more efficient feed conversion, reduced nitrogen excretion and a higher protein accretion compared to barrows and gilts.

Despite an agreement among many European swine industry stakeholders to ban surgical castration by 2018, most male piglets in Europe are still castrated without pain relief or anesthesia, the report noted. But according to the researchers, a technique known as immunological castration (also known as immunocastration) could provide a sustainable alternative by helping European producers harness the economic and environmental benefits of boar production while mitigating risks to welfare and product quality.

Immunological castration

Immunological castration involves vaccinating male pigs against gonadotropin-releasing hormone, thereby delaying the onset of puberty. As a result, the technique has been shown to reduce the accumulation of androstenone and skatole, the naturally occurring compounds that are responsible for boar taint.

The vaccine, marketed in Europe as Improvac®, is given in two doses: The first dose, which is recommended around 12 weeks of age, serves to prime the immune system. But the puberty-delaying effects of the vaccine don’t kick in until after the second dose, which is given about 4 to 6 weeks before slaughter.

This means that vaccinated pigs spend most of the fattening period growing like boars, which gain more weight, convert feed more efficiently and produce less manure compared to barrows and gilts.

Following the second dose, vaccinated pigs switch from boar to barrow-like status, and growth efficiency drops. But on the plus side, boar-taint risk is limited, aggressive behavior is reduced, and the pigs deposit fat in a way that is more consistent with barrows and generally considered more palatable to consumers.

Filling knowledge gaps

Immunological castration therefore provides a higher-welfare alternative to physical castration that allows producers to strike a balance between the naturally superior growth efficiency of boars and the behavioral and meat-quality benefits of barrows. However, despite being approved in Europe since 2009 and widely used in markets such as Canada, Brazil, Australia and several others, the researchers noted that the technique is still not widely used in Europe.

“Little practical experience of stakeholders and no targeted communication about the consequences of [immunological castration] of European pig genotypes for management, feed requirements and product quality exist in the market,” the researchers wrote, adding that these knowledge gaps may explain why a method that might have economic, ecological and societal advantages is still not widely embraced.

To address the knowledge gaps, the researchers conducted a comprehensive review of scientific literature to demonstrate the benefits and trade-offs of the vaccine according to the three pillars of sustainability: society (including animal health, welfare and product quality), economy (including production performance and carcass quality) and the environment (including feed conversion and natural resource use).

They also looked at how interactions between various factors of sustainability can lead to synergic and conflicting relationships both within and among the pillars (Figure 1).2


For example, they wrote, “In immunocastrates, performance results are better than in barrows but worse than in boars. The environmental impact of pork production with immunocastrates is lower than with barrows but higher than with boars.”

Compared to boars, the level of aggression is considerably lower in vaccinated pigs, they added. Meanwhile, societal concerns are mainly related to food safety and are not supported by any scientific evidence.

Finding the right balance

Since vaccinated pigs perform like barrows following the second vaccination, the researchers suggested that the timing of the second dose may allow producers to tailor product quality to the demands of different pork markets. Ultimately, they said, the decision has to be balanced between the conflicting aims of desirable, boar-like growth efficiency and lean meat content, on the one hand, with the superiority of barrows in terms of behavior and meat quality on the other.

“High product quality with low boar-taint levels and higher levels of intramuscular fat work well with production systems which optimize welfare aspects through an early second vaccination. These advantages have to be balanced against the higher anabolic potential of boars which can create economic and environmental benefits,” they wrote.

“The later the second vaccination is applied, the better its effects for the environment and for farm profitability.

“Within the value chain, targeted communication about the impact of the timing of the second vaccination is essential in order to make use of this opportunity to produce meat quality tailored to various market segments with different impacts on sustainability.”

To read the full article, click here.



1 Kress K, et al. Sustainability of Pork Production with Immunocastration in Europe. Sustainability. 2019;11(12):3335. https://doi.org/10.3390/su11123335
2 Ibid.



Share It
Immunological castration could make swine production more sustainable — but sometimes the goals of sustainability conflict. Tools to help producers find the right balance for their markets are critical to the practice gaining wider acceptance.

Click an icon to share this information with your industry contacts.

Posted on November 26, 2021

tags: ,

You must be logged in to edit your profile.

Share It
When a sow doesn’t reach her full potential, the cost to the farm and the income stream of the sow herd is often “grossly underestimated,” said John Deen, DVM, PhD, a professor at the University of Minnesota.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.